title: Improving outcomes after intestinal transplantation at the University of California, Los Angeles.
abstract: This study summarizes a two decade experience with ITx at a single institution. It represents one of the largest such reports on the subject. Results indicate that a significant improvement in outcome has occurred since 2000. This improvement relates to center experience, induction immunotherapy, surgical techniques along with the reduction in CMV and EBV disease. Further advancements will require more focused analyses on outcomes after ITx.
authors.affiliation: Department of Surgery, David Geffen School of Medicine, UCLA, USA.
authors.forename: Douglas G
authors.initials: DG
authors.lastname: Farmer
authors.forename: Robert S
authors.initials: RS
authors.lastname: Venick
authors.forename: Ronald W
authors.initials: RW
authors.lastname: Busuttil
mesh_terms: D000046:Academic Medical Centers; D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D005260:Female; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007223:Infant; D007231:Infant, Newborn; D007422:Intestines / Q000276:immunology / Q000637:transplantation*; D053208:Kaplan-Meier Estimate; D015141:Los Angeles; D008297:Male; D016377:Organ Transplantation / Q000009:adverse effects / Q000401:mortality; D016730:Program Development; D015397:Program Evaluation; D016016:Proportional Hazards Models; D012189:Retrospective Studies; D018570:Risk Assessment; D012307:Risk Factors; D015996:Survival Rate; D013997:Time Factors; D009927:Tissue and Organ Procurement; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D007166:Immunosuppressive Agents